Fred Hutchinson Cancer Center
Seattle, WA Doing business as Seattle Cancer Care Alliance
- UEI
- TJFZLPP6NYL6
- CAGE
- 50WB4
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1100 Fairview Ave N, Seattle, WA 98109, USA
- Website
- fredhutch.org
- Founded
- 1975
- Employees
- 5K-10K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | -$91,684 |
| FY2026 | $24,368,208 |
| FY2025 | $21,579,862 |
| FY2024 | $21,414,195 |
| FY2023 | $22,274,495 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $24,091,474 | |
| 2 | Department of Veterans Affairs | $185,050 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| The Trustees Of The University Of Pennsylvania | 75N93021C00015 | $590,411 | |
| ST Jude Children's Research Hospital Inc. | 75N93021C00016 | $334,369 | |
| ST Jude Children's Research Hospital Inc. | 75N93021C00016 | $254,583 | |
| ST Jude Children's Research Hospital Inc. | 75N93021C00016 | $202,263 | |
| Westat, Inc. | 75Q80125F32002 | $220,002 |
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | R01AT012826 | $2,085,318 | |
| Vanderbilt University Medical Center | U01CA292550 | $97,192 | |
| Regents Of The University Of Michigan | R01DE033668 | $81,391 | |
| The Johns Hopkins University | R01AI194979 | $119,757 | |
| Georgia TECH Research Corp | R01CA304559 | $365,128 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Fred Hutchinson Cancer Center, doing business as Seattle Cancer Care Alliance, is a tax-exempt non-profit research institution that acts as a prime recipient of federal grants and a prime contractor on federal service contracts, with a secondary role as a subcontractor to larger federal research primes. The center is a National Cancer Institute-designated comprehensive cancer center headquartered in Seattle, Washington, and operates primarily as a recipient of federal grants supporting biomedical research and clinical trials rather than as a goods or services vendor.
Fred Hutchinson's federal footprint is dominated by research grants and clinical research contracts. The center receives grant funding across multiple NIH institutes and centers, with the National Cancer Institute anchoring approximately 36% of the award count (412 awards carrying $649.8 million in combined potential value). The National Institute of Allergy and Infectious Diseases follows with 282 awards, the National Heart, Lung and Blood Institute with 72 awards (worth $146.1 million), and the National Institute of General Medical Sciences with 51 awards. Beyond NIH, the Defense Health Agency has funded 47 awards. Recent representative grant work includes a $49.925 million definitive contract with the National Cancer Institute to operate the Cancer Information Service, a bilingual contact center delivering cancer information and clinical trial support (awarded May 1, 2025, with ultimate completion April 30, 2030); a $20.6 million delivery order from the National Heart, Lung and Blood Institute to serve as Clinical Coordinating Center for the Women's Health Initiative (February 1, 2026, completing January 31, 2028); and a $4.23 million Cooperative Agreement from the NCI to conduct comprehensive characterization of T-cell immune responses to Kaposi Sarcoma Herpesvirus (September 19, 2025, through August 31, 2029). Grant recipients and sub-recipients work across infectious disease, cancer treatment and prevention, aging research, and vaccine development.
The center's service-contract activity, captured in the Service Contract Inventory above the $150,000 reporting threshold, shows stable federal services delivery. SCI-reported invoicing totaled $86.8 million across FY2022–FY2025, with FY2024 reaching $24.6 million across 115 FTEs and FY2025 invoicing $22 million across 112 FTEs. Government-paid rates on these prime contracts span a median of $132.50 per hour, with the 10th percentile at $66.02/hr and the 90th percentile at $337.67/hr, reflecting a mix of clinical research coordinators, laboratory technicians, and senior scientific staff. Across SCI-reportable prime contracts, subcontractors performed approximately 10% of total contractor hours, with 20 named subcontractors identified across the portfolio.
Award activity has grown substantially. The center received 74 awards in 2022, increasing to 220 in 2024 and 228 in 2025, before declining to 149 in 2026 (a partial year). The combined potential value across all 1,139 awards in the source is $804.1 million, though the center has obligated $10.12 billion across these awards—a figure indicating that many grants carry multi-year funding structures with annual obligations exceeding single-year potential values. One hundred eighty awards are scheduled to complete within the next twenty-four months, representing $70.4 million in combined potential value and creating recompete exposure across those programs.
Fred Hutchinson operates as a sub-recipient on grants where it receives sub-awards from prime-recipient institutions (including the University of Washington, Seattle Children's Hospital, Emory University, The Johns Hopkins University, Yale University, and others) to conduct specialized analytical, immunological, or computational work nested within larger clinical trials or epidemiological studies. As a prime, the center contracts with subcontractors at lower rates, retaining approximately 90% of contractor hours in-house. The center does not compete under federal set-asides and does not hold GSA schedule positions or seats on government-wide acquisition contracts; its federal footprint is exclusively grant-based and research-contract-based, with no commercial product or service sales to federal customers.
Quick answers
Is Fred Hutchinson Cancer Center registered in SAM.gov?
Yes. Fred Hutchinson Cancer Center's SAM.gov registration is active through March 26, 2027.
How much has Fred Hutchinson Cancer Center received in federal contracts?
Federal contracts obligated $21,579,862 to Fred Hutchinson Cancer Center in fiscal year 2025 and $89,545,075 in fiscal years 2023 through 2027.
How does Fred Hutchinson Cancer Center rank among federal contractors?
Fred Hutchinson Cancer Center ranked #5 in NAICS 561422, #6 in NAICS 56142 and #15 in PSC AN12 in FY2025.
What is Fred Hutchinson Cancer Center's most recent federal award?
Fred Hutchinson Cancer Center's most recent federal grant award is Investigating the role of NOTCH1 in immunogenicity and LSD1 inhibitor therapy in small cell lung cancer (F31CA306056), from National Cancer Institute (NIH), on December 1, 2026.
On GovTribe
See Fred Hutchinson Cancer Center's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors